Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes

被引：0
|
作者：
Ang, L. [1 ]
Kidwell, K. [2 ]
Dillon, B. [3 ]
Reiss, J. [1 ]
Leone, V. [4 ]
Mizokami-Stout, K. [1 ]
Busui, R. [1 ]
机构：
[1] Univ Michigan, Metab Endocrinol & Diabet Div, Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Ann Arbor, MI USA
[4] Univ Michigan, Metab Endocrinol & Diabet Div, Ann Arbor, MI 48109 USA
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
844
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [21] Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Chung, Jin Ook
    Park, Seon-Young
    Cho, Dong Hyeok
    Chung, Dong Jin
    Chung, Min Young
    [J]. MEDICINE, 2017, 96 (15)
  • [22] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [23] Cardiovascular autonomic function and vibration perception threshold in type 2 diabetes mellitus
    Goit, Rajesh Kumar
    Khadka, Rita
    Sharma, Sanjib Kumar
    Limbu, Nirmala
    Paudel, Bishnu Hari
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2012, 26 (04) : 339 - 342
  • [24] Hypoxia as a reversible cause of cardiovascular autonomic dysfunction in patients type 2 diabetes and impaired renal function
    Bernardi, L.
    Esposito, P.
    Bianchi, L.
    Mereu, R.
    DeBarbieri, G.
    Dal Canton, A.
    Groop, P. -H.
    [J]. DIABETOLOGIA, 2015, 58 : S504 - S504
  • [25] Osteopontin: A Potential Determinant of Cardiovascular Autonomic Nerve Function in Type 2 Diabetes
    Maser, Raelene E.
    Lenhard, M. James
    Pohlig, Ryan T.
    [J]. DIABETES, 2015, 64 : A164 - A165
  • [26] Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function
    Maser, Raelene E.
    Lenhard, M. James
    Pohlig, Ryan T.
    Balagopal, P. Babu
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (03) : 507 - 510
  • [27] Efficacy and Safety of Dapagliflozin for Type 2 Diabetes Mellitus Patients With a History of Cardiovascular Disease
    Leiter, Lawrence A.
    Cefalu, William T.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    [J]. DIABETES, 2012, 61 : A287 - A287
  • [28] Dapagliflozin Treatment for Type 2 Diabetes Mellitus Patients With Comorbid Cardiovascular Disease and Hypertension
    Cefalu, William T.
    Leiter, Lawrence A.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    [J]. DIABETES, 2012, 61 : A271 - A271
  • [29] HYPERTRIGLYCERIDEMIA AND CARDIOVASCULAR AUTONOMIC FUNCTION IN PATIENTS WITHOUT DIABETES
    Bashir, Bilal
    Ferdousi, Maryam
    Pasha, Raabya
    Kamath, Anoushka
    Kolakaluri, Eirene
    Baptist, Mariamma
    Soran, Handrean
    [J]. ATHEROSCLEROSIS, 2024, 395
  • [30] Anatomical Differences in the Association of Sudomotor Function and Cardiovascular Autonomic Function in Type 2 Diabetes Mellitus
    Maser, Raelene E.
    Lenhard, M. James
    Pohlig, Ryan T.
    Balago-Pal, P. Babu
    [J]. DIABETES, 2017, 66 : A146 - A146
12345